Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-240148
Filing Date
2024-10-21
Accepted
2024-10-21 11:47:56
Documents
8
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 6-K d857882d6k.htm 6-K 8767
2 EX-99.1 d857882dex991.htm EX-99.1 21690
3 EX-99.2 d857882dex992.htm EX-99.2 28374
4 GRAPHIC g857882g1021170200023.jpg GRAPHIC 2601
5 GRAPHIC g857882page0001.jpg GRAPHIC 1567
6 GRAPHIC g857882page1a.jpg GRAPHIC 5154
7 GRAPHIC g857882page4b.jpg GRAPHIC 12603
8 GRAPHIC g857882page4c.jpg GRAPHIC 4534
  Complete submission text file 0001193125-24-240148.txt   97228
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241382444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)